| scholarly article | Q13442814 |
| P2093 | author name string | F. Ellis | |
| P2860 | cites work | THE ESTIMATION OF TOTAL DOSE FOR DIFFERENT NUMBERS OF FRACTIONS IN RADIOTHERAPY | Q78310294 |
| Time-dose relationship in Hodgkin's disease | Q79026678 | ||
| The treatment of carcinoma of the larynx by supervoltage radiotherapy | Q79026824 | ||
| Quantitative Biological Dose Control in Interstitial Radium Therapy | Q82177072 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1-7 | |
| P577 | publication date | 1969-01-01 | |
| P1433 | published in | Clinical Radiology | Q15754925 |
| P1476 | title | Dose, time and fractionation: a clinical hypothesis | |
| Dose, time and fractionation: A clinical hypothesis | |||
| P478 | volume | 20 |
| Q48904154 | A 100-year Nordic perspective on the dose-time problem in radiobiology |
| Q36993295 | A Comparative Study of Daily 3-Gy Hypofractionated and 1.8-Gy Conventional Breast Irradiation in Early-Stage Breast Cancer |
| Q41313023 | A comparative study of two preoperative radiation regimens with cystectomy for bladder cancer |
| Q52403996 | A new theoretical formula for fractionated radiotherapy based on a saturable cellular repair mechanism. |
| Q42458782 | A trial of radiation dose prescription based on dose-cell survival formula |
| Q68096072 | AO reconstruction plate systems for the repair of mandibular defects 3-DBRP versus Thorp-system |
| Q71006156 | An ISO-effect table for radiation tolerance of the human spinal cord |
| Q43449270 | An analysis of factors in the successful management of cancer of tonsillar region |
| Q69626514 | Analysis of interaction for mixtures of agents using the linear isobole |
| Q43880537 | Application of radiation effect models in combined external and intracavitary radiotherapy of carcinoma of the uterine cervix |
| Q41870792 | Applications of computers in treatment planning |
| Q52119953 | BED-time charts and their application to the problems of interruptions in external beam radiotherapy treatments. |
| Q40796657 | Basic mechanisms and general morphology of radiation injury |
| Q33853833 | Benefits of adjuvant radiotherapy after radical resection of locally advanced main hepatic duct carcinoma |
| Q48375214 | Bilateral temporal lobectomy for necrosis induced by radiotherapy for nasopharyngeal carcinoma |
| Q39174740 | Biological effects and equivalent doses in radiotherapy: A software solution |
| Q36149662 | Brachytherapy for brain tumors |
| Q48762297 | Brain irradiation for metastatic disease of lung origin |
| Q35816527 | Cancer and radiation therapy: current advances and future directions |
| Q53732823 | Cancer of the nasopharynx. Incidence, clinical course and results of therapy: a report from Greece. |
| Q41785947 | Carcinoma of the Larynx V. Relationship between biologic effect and failure of irradiation |
| Q57618533 | Carcinoma of the cervix and the use of hyperbaric oxygen with radiotherapy: a report of a randomised controlled trial |
| Q39553227 | Carcinoma of the esophagus. Pretreatment assessment, correlation of radiation treatment parameters with survival, and identification and management of radiation treatment failure |
| Q39420372 | Carcinoma of the esophagus: surgery versus radiotherapy |
| Q66985453 | Carcinoma of the nasopharynx an optimization of radiotherapeutic management for tumor control and spinal cord injury |
| Q70237141 | Cardiac damage in autologous bone marrow transplant patients: an autopsy study. Cardiotoxic pretreatment as a major risk factor |
| Q39726699 | Cell kinetics and radiation biology |
| Q36855956 | Central nervous system injury by therapeutic irradiation. |
| Q40565861 | Cerebral necrosis following radiotherapy of extracranial neoplasms |
| Q39671372 | Clinical course of early extranodal non-Hodgkin's lymphomas |
| Q26865336 | Clinical implementation of a new electronic brachytherapy system for skin brachytherapy |
| Q41552608 | Clonogenic Potential of Human Tumors A hypothesis |
| Q69558529 | Combination chemotherapy and radiation therapy in small cell carcinoma of the lung |
| Q67867655 | Comments on “predicting normal tissue injury in radiation therapy” |
| Q40990790 | Comparative trial of large and small fractions in the radiotherapy of head and neck cancer |
| Q66896323 | Comparison of skin erythemas under two different fractionation schemes |
| Q69737705 | Complications of radiation therapy: The thorax |
| Q69510587 | Conformation therapy: a method of improving the tumour treatment volume ratio |
| Q67017110 | Continuous and fractionated irradiation of mammalian cells in culture—I. The effect of growth rate |
| Q52712133 | Cumulative Radiation Damage and Cumulative Radiation Effect |
| Q53002736 | Cumulative radiation effect part I: Fractionated treatment regimes |
| Q52439473 | Definition of T in the NSD equation |
| Q40221776 | Delayed cerebral pseudo-tumoral radionecrosis following scalp-tumour irradiation. Case report and review of literature |
| Q70332681 | Dental extractions in relation to radiation therapy of 224 patients |
| Q52713691 | Dependence of tolerance dose on irradiated volume in radiotherapy, and determination of volume corrected time, dose and fractionation factors. |
| Q39975090 | Desmoid tumor associated with cystosarcoma phyllodes of the breast |
| Q34376122 | Development of clinical radiotherapy since 1896. |
| Q39637601 | Dose Distribution in 42 MV Roentgen Irradiation of Cervical Carcinoma |
| Q66908760 | Dose and treatment factors in radiation related pericardial effusion associated with the mantle technique for Hodgkin's disease |
| Q39098388 | Dose response in radiotherapy for glottic carcinoma |
| Q37876669 | Dose tolerance limits and dose volume histogram evaluation for stereotactic body radiotherapy |
| Q54974398 | Dose tolerance limits and dose volume histogram evaluation for stereotactic body radiotherapy. |
| Q71223802 | Dose-incidence curves for tumour control and normal tissue injury, in relation to the response of clonogenic cells |
| Q72825368 | Dose-response relationships for human tumors: Implications for clinical trials of dose modifying agents |
| Q41282174 | Dose-time relationships for post-irradiation cutaneous telangiectasia |
| Q35174679 | Early delayed radiation injury to the brainstem after radiotherapy for lymphoma of the tongue and neck |
| Q39510364 | Effectiveness of local radiotherapy in colorectal carcinoma |
| Q70188783 | Effects Of Dose Fractionation On Late Roentgen Radiation Damage Of Rat Small Intestine |
| Q44473178 | Effects of fractionated irradiation on mouse lung and a phenomenon of slow repair |
| Q69756411 | Effects of the radiation at the entrance point of a negative π-meson beam |
| Q44177727 | Efficacy and toxicity of replication-competent adenovirus-mediated double suicide gene therapy in combination with radiation therapy in an orthotopic mouse prostate cancer model |
| Q39621521 | En-Bloc Irradiation of Tumours of the Head and Neck and Their Lymphatics: II. Early results and side effects |
| Q34444303 | Endocrine sequelae of cancer therapy in childhood |
| Q44277121 | Epidermoid carcinoma of the larynx. VI. Histologic grading in the clinical evaluation |
| Q36078872 | Experimental radiation-induced heart disease. I. Light microscopic studies |
| Q47368780 | Forty years of landmark trials undertaken by the Danish Breast Cancer Cooperative Group (DBCG) nationwide or in international collaboration. |
| Q72399849 | Fractionated Radiation Therapy after Strandqvist |
| Q40863850 | Fractionation in radiotherapy: a view from the clinic |
| Q45253218 | Fractionation schedules and a quadratic dose-effect relationship |
| Q42440364 | Fractionation scheme with low individual tumour dose and high total dose |
| Q71469043 | Free flaps and irradiated recipient vessels: an experimental study in rabbits |
| Q38096409 | Future radiation therapy: photons, protons and particles |
| Q68521650 | Gastrointestinal morbidity of adjuvant radiotherapy in stage I malignant teratoma of the testis |
| Q44574209 | General Equation for the Calculation of Nominal Standard Dose |
| Q43901445 | General equations for the calculations of biologic effect ratios for parallel opposing fields |
| Q37886345 | Glomus jugulare tumours in South Wales — A twenty-year review |
| Q43583383 | Glucocorticoid dependency as a prognostic factor in radiotherapy for cerebral gliomas |
| Q34987031 | Growth and hormonal status of children treated for acute lymphoblastic leukaemia |
| Q41455285 | Growth and neuroendocrine dysfunction following therapy for childhood cancer |
| Q40409865 | Growth following therapy for childhood cancer |
| Q72865344 | Half-body and local chest irradiation as consolidation following response to standard induction chemotherapy for disseminated small cell lung cancer: An Eastern Cooperative Oncology Group Pilot Report |
| Q44981977 | Heart disease after mediastinal radiotherapy |
| Q40020396 | High dose radiation therapy in the treatment of glioblastoma multiforme: A preliminary report |
| Q66985474 | Hyperbaric oxygen after irradiation and its effects on the production of radiation myelitis |
| Q41482096 | Hyperfractionation: where do we stand? |
| Q39628572 | Immediate results of weekly fractionation in external radiotherapy |
| Q38605767 | Impact of radiation research on clinical trials in radiation oncology |
| Q27011493 | In silico modelling of treatment-induced tumour cell kill: developments and advances |
| Q69664783 | Increased skeletal uptake of radiocolloid due to metastatic liver disease |
| Q34239497 | Increasing radiation dose intensity using hyperfractionation in patients with malignant glioma. Final report of a prospective phase I-II dose response study |
| Q44105630 | Iodine 125 interstitial irradiation for localized prostate cancer. |
| Q40804631 | Ionizing radiation therapy in dermatology |
| Q48504589 | Irradiation of brain metastases |
| Q72382060 | Irradiation, chemotherapy and surgery in esophageal cancer: a randomized clinical study. The first Scandinavian trial in esophageal cancer |
| Q48909498 | Large dose increment irradiation in treatment of cerebral metastases |
| Q41548475 | Laryngeal carcinoma. IV. Analysis of treatment results using the Cohen model |
| Q36286960 | Late effects of radiotherapy in the treatment of breast cancer |
| Q69959230 | Late post-radiotherapy progressive myelopathy |
| Q52893220 | Letter: Fractionation schedules and dose-effect relationships. |
| Q52905428 | Letter: NSD calculations--a simple graphical method. |
| Q44820845 | Letter: Recent advances in the development of a 14 MeV neutron generator suitable for radiotherapy |
| Q52888794 | Letter: The overall treatment time in radiotherapy. |
| Q69929819 | Logic in radiotherapeutic trials |
| Q41052275 | Magnus Strandqvist: 50th anniversary of his doctoral thesis |
| Q46393426 | Mathematical derivation of optimal treatment schedules for the radiotherapy of human tumours. Fractionated irradiation of exponentially growing tumours |
| Q52132288 | Mathematical models of tumour and normal tissue response. |
| Q41282194 | Medical liability in the practice of therapeutic radiology |
| Q70162034 | Megavolt Electron Irradiation in the Treatment of Recurrent Carcinoma of the Breast on the Chest Wall |
| Q37532183 | Milestones in normal tissue radiation biology over the past 50 years: from clonogenic cell survival to cytokine networks and back to stem cell recovery |
| Q54198399 | Misonidazole in fractionated radiotherapy: are many small fractions best? |
| Q34033298 | Morbidity related to axillary irradiation in the treatment of breast cancer |
| Q70686640 | Multifraction irradiation of mouse bladders |
| Q39637591 | Neurologic Complications After Irradiation of Malignant Tumors of the Testis |
| Q34137824 | Normal tissue radiobiology: from the laboratory to the clinic. |
| Q39634163 | Optimization of external beam radiotherapy: Quantitative study of relative radiation effects and isoeffect patterns using PC-12 computer |
| Q69968999 | Oral findings in irradiated edentulous patients |
| Q40020415 | Osteoradionecrosis of the temporal bone—Consideration of nominal standard dose |
| Q43590023 | Parathyroid hormone and calcitonin in serum of patients with mammary carcinoma |
| Q93600550 | Patterns of cell loss and repopulation in irradiated cultures of plateau phase C3H 10T 1/2 cells |
| Q30660196 | Phase II, two-arm RTOG trial (94-11) of bischloroethyl-nitrosourea plus accelerated hyperfractionated radiotherapy (64.0 or 70.4 Gy) based on tumor volume (> 20 or < or = 20 cm(2), respectively) in the treatment of newly-diagnosed radiosurgery-ineli |
| Q45221601 | Postoperative complications after combined treatment for carcinoma of the tongue |
| Q40094272 | Postoperative radiotherapy in DBCG during 30 years. Techniques, indications and clinical radiobiological experience |
| Q41685837 | Postoperative split course radiotherapy of squamous cell carcinoma of the oral tongue |
| Q35588277 | Pre-operative and post-operative radiotherapy and rectal cancer |
| Q44543637 | Preoperative radiation therapy for clinically resectable adenocarcinoma of the rectum |
| Q39671459 | Primary radiotherapy for carcinoma in situ and early invasive carcinoma of the glottic larynx |
| Q40821957 | Quantitative clinical radiobiology |
| Q52749265 | Radiation Damage to the Rat Spinal Cord A radiobiologic model |
| Q48711280 | Radiation Sensitivity of Tissues Irradiated During Mantle Treatment of Hodgkin's Disease |
| Q37948834 | Radiation and hypothalamic-pituitary function |
| Q36347796 | Radiation enteritis in children.A retrospective review, clinicopathologic correlation, and dietary management |
| Q48261293 | Radiation fractionation: the search for isoeffect relationships and mechanisms. |
| Q54540628 | Radiation induced pericarditis in Hodgkin's disease. |
| Q36992661 | Radiation myelopathy |
| Q67318186 | Radiation myelopathy of the cervical spinal cord: Time, dose and volume factors |
| Q37986496 | Radiation necrosis: relevance with respect to treatment of primary and secondary brain tumors |
| Q67562447 | Radiation osteitis following irradiation for breast cancer |
| Q40256868 | Radiation physiology - evidence for a higher biological effect of 24 Gy in four fractions as compared to three |
| Q39799381 | Radiation therapy for tumors of the pineal region |
| Q71093310 | Radiation-induced parathyroid adenomas and thyroid tumors in rats |
| Q55490529 | Radio- and chemotherapy of malignant gliomas. Pathological changes in the normal nervous tissue |
| Q39390521 | Radiobiological aspects of fast neutron therapy. |
| Q51169838 | Radiobiological rationale for compensation for gaps in radiotherapy regimens by post-gap acceleration of fractionation. |
| Q67339331 | Radioprotection of the digestive tract by intravenous infusion of vasopressin |
| Q40544521 | Radiosensitization by misonidazole (Ro-07-0582) of fractionated X-rays in a murine tumour |
| Q78944713 | Radiotherapy alone in the treatment of uterine cervix cancer with telecobalt and low-dose-rate brachytherapy: retrospective analysis of results and variables |
| Q39442595 | Radiotherapy and hyperbaric oxygen in head and neck cancer. Interim report of second clinical trial |
| Q67318202 | Radiotherapy and medical oncology: Basis for cooperative relations |
| Q44397138 | Radiotherapy for intracranial metastases |
| Q42442362 | Radiotherapy of cutaneous cancers and some other malignancies |
| Q40364596 | Radiotherapy of liposarcomas |
| Q40300677 | Reactions to ionizing radiation |
| Q43674707 | Reirradiation for recurrent cerebral astrocytoma |
| Q66955013 | Relative effectiveness of 12-hourly fractionation and a non-uniform X-ray schedule in the optimum fractionation of C3H mouse mammary tumours |
| Q52698312 | Repair factors for multifraction irradiations. |
| Q39650662 | Repopulation in human tumors. A biological background for fractionation in radiotherapy |
| Q48458974 | Response of rat brain tissue for the extraction of 125I antipyrine after single and fractionated roentgen ray doses. A comparison of fractionation models applied to the central nervous system |
| Q43965512 | Retrospective analysis of nasopharyngeal carcinoma treated during 1976-1985: late complications following megavoltage irradiation |
| Q67832358 | Review of parameters characterising response of normal connective tissue to radiation |
| Q36602055 | Review: total doses in fractionated radiotherapy--implications of new radiobiological data |
| Q70396692 | Role of elective brain irradiation during combined chemoradiotherapy for limited disease non-small cell lung cancer |
| Q35908320 | Safety Profile of Amnion-Derived Cellular Cytokine Solution (ACCS) Following Topical Skin Application in Patients Receiving Breast Radiotherapy. |
| Q68377743 | Single-dose radiation therapy for prevention of heterotopic ossification after total hip arthroplasty |
| Q67351205 | Skin Reactions After Different Fractionation Schedules Giving the Same Cumulative Radiation Effect |
| Q69756382 | Skin tolerance to fractionated X-irradiation in the pig—how good a predictor is the NSD formula? |
| Q44364848 | Some factors of importance in the radiation treatment of malignant melanoma |
| Q39461192 | Splenic irradiation in the palliation of patients with lymphoproliferative and myeloproliferative disorders |
| Q53853660 | Split-Course Radiation Therapy of Mediastinal Hodgkin's Disease: TSD and CRE concepts |
| Q72635359 | Superfractionated Irradiation Combined with Low Doses of Bleomycin in the Treatment of Oral Carcinoma |
| Q52888098 | Tables for use in NSD calculations. |
| Q36601299 | The Cancer Research Campaign (King's/Cambridge) trial for early breast cancer: an analysis of the radiotherapy data |
| Q52937255 | The Ellis formula |
| Q70349082 | The Ellis formulae for X rays and fast neutrons |
| Q36639294 | The Impact of Radiotherapy Dose on Local Control of Ewing's Sarcoma of Bone |
| Q40726047 | The Relationship between O.E.R., R.B.E. and Number of Fractions for X-ray- or Neutron-induced Skin Damage |
| Q72901791 | The characteristics of long-term survivors of lung cancer treated with radiation |
| Q41677124 | The dose—time relationship in the radiotherapy of carcinoma of the cervix uteri: An application of the CRE formalism |
| Q52404383 | The effect of differing radiotherapeutic schedules on the response of glottic carcinoma of the larynx. |
| Q54639370 | The effect of recovery from potentially lethal damage on the determination of repair and repopulation in a murine tumour. |
| Q42858051 | The effect of small radiation doses on mouse skin |
| Q41077353 | The effects of varied numbers of dose fractions on the tolerance of normal human skin |
| Q40169933 | The first James Kirk memorial lecture. What next in fractionated radiotherapy? |
| Q70955566 | The irradiated wound |
| Q39999363 | The kinetics of tumour cell proliferation and radiotherapy |
| Q38678064 | The linear-quadratic formula and progress in fractionated radiotherapy |
| Q72361997 | The oxford NSD calculator for clinical use |
| Q52966048 | The problem of alternate treatment days |
| Q44041091 | The relationship between total dose, number of fractions and fractions size in the response of malignant melanoma in patients |
| Q52743651 | The relationship of dose to prognosis in squamous-cell carcinoma of the aerodigestive tract. |
| Q43599201 | The response of mouse skin to fractionated X rays |
| Q39829137 | The response of pig skin to single and fractionated high dose-rate and continuous low dose-rate 137Cs-irradiation—II. Theoretical considerations of the results |
| Q66893421 | The results of treatment of cancer of the bladder—A clinical contribution to radiobiology |
| Q37345399 | The role of medical physicists and the AAPM in the development of treatment planning and optimization |
| Q70497548 | The role of radiation in the treatment of cancer:radiobiologic and cell kinetic concepts |
| Q39582856 | The role of radiotherapy in the management of malignant hemangiopericytoma.Report of eleven new cases and review of the literature |
| Q52431666 | The sensitivity of normal stroma to fractionated radiotherapymeasured by a tumour growth rate assay |
| Q52647871 | The time-dose relationship for radiation-induced lung damage in pigs. |
| Q40727895 | The translational research chain: is it delivering the goods? |
| Q41846818 | The treatment of squamous cell carcinoma of the paranasal sinuses |
| Q52771345 | The utility of computed tomography in radiation therapy: An estimate of outcome |
| Q52428164 | The value of the NSD formula in equation of acute and late radiation complications in normal tissue following 2 and 5 fractions per week in breast cancer patients treated with postmastectomy irradiation. |
| Q35552500 | Time factor for acute tissue reactions following fractionated irradiation: a balance between repopulation and enhanced radiosensitivity |
| Q68476806 | Time-dose response of human tumors and normal tissues during and after fractionated radiation treatment. A new model |
| Q44529208 | Transforming growth factor beta: a promotor of late connective tissue injury following radiotherapy? |
| Q43427242 | Treatment outcome following radiotherapy in elderly patients with bladder cancer |
| Q38617591 | Tumor cell proliferation kinetics and tumor growth rate |
| Q39241842 | Two regimes with the same TDF but differing morbidity used in the treatment of stage III carcinoma of the cervix |
Search more.